Plus Therapeutics Inc at ThinkEquity Conference Transcript
Everyone, thank you all for coming. My name is Nick Christian. I'm with ThinkEquity. And our next presenting company is Plus Therapeutics. So I'll turn it over to them.
Thanks a lot, Nick. How's the auditory? All good?
Yeah, my name is Marc Hedrick. I'm the President, CEO of Plus Therapeutics. So just a little bit of an overview of the company. We're a Texas-based targeted radiotherapeutic company, developing treatments for some of the worst cancers on the planet, different kinds of brain cancer and metastatic and inoperable liver cancer.
One unique aspect about the company is we've been able to obtain funding for our lead programs through Phase 2, both from the NIH in the state of Texas. The state of Texas is actually the second largest funder of cancer research in the world behind the NIH. We just received almost a $20 million grant from CPRIT, which is the funding agency in Texas.
So, as I mentioned, we're going after some of the toughest,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
